3rd International Conference on

Women Health & Breast Cancer

Theme: Discovering health issues and finding way to improve Women Health

Event Date & Time

Event Location

Dubai, UAE

18 years of lifescience communication

17345684571

Performers / Professionals From Around The Globe

Tracks & Key Topics

Women Health 2019

INVITATION

It’s time to take care of you. So, on behalf of Euroscicon we are glad and privileged to invite you to join the 3rd International Conference on Women Health and Breast Cancer which is going to be held in Dubai, UAE on January 28-29, 2019.

The theme of the conference is aiming to promote quality research and real-world impact in an atmosphere of true international cooperation between scientists by bringing together again the world class researchers, International Communities and Industrial heads to discuss the latest developments and innovations in the fields of Women Health and Breast Cancer.

During this conference will have the opportunity to interact with more than 50 world-renowned speakers in the field of women health, sharing their expertise and experiences.

Dubai is an exceptional location for the conference. It is the largest  and the most populous city of United Arab Emirates.

Women Health 2019 will provide a wonderful forum for you to refresh your knowledge base and explore the innovations in women’s health care and breast cancer. The Conference will strive to offer plenty of networking opportunities, providing you with the opportunity to meet and interact with the leading scientists and researchers, friends and colleagues as well as sponsors and exhibitors.

Women Health 2019 Exhibition will provide valuable opportunity to retailers and manufacturers within the industry in Middle-East to share their products and technologies with worldwide manufactures and industry specialists.

We hope your experience in 3rd International Conference on Women Health and Breast Cancer will be outstanding. Our expectations that each candidate will return home and carry the valuable knowledge he acquired in these two days into a new successful practice for many years to come!

 

With best wishes,

Organizing Committee

Women Health 2019

 

ABOUT CONFERENCE

Following the success of our previous conferences, we are pleased to announce that Women Health 2019 is going to offer contributors a global platform to share skills, increase their knowledge and to enhance the competence of attendees.

Women Health 2019 anticipates more than 300 participants around the globe with thought provoking plenary speakers, established keynote speakers, active invited speakers and fresh contributed speakers. In addition, variety of poster presentations along with workshops and special sessions would be interesting for audience. This is an excellent opportunity for delegates from Universities and Institutes to interact with the world class Scientists. It aims to give opportunity to International Communities and Industrial heads to discuss the latest developments and innovations in the fields of Women Health and Breast Cancer.

It aims to offer professionals in the field of multidisciplinary platform to learn more about the women’s health, gynecological research and discovery. This conference is designed to empower healthcare providers to assist women in making informed decisions about health, well-being and personal safety. The agenda is designed to provide camaraderie and instruction for physicians, midwives, nurse practitioners, pharmacists and physician assistants with a broad range of topics relevant to women’s health. The conference will gather a prestigious group of physicians, nurses, and allied healthcare providers to provide practical, clinical information about cutting-edge therapeutic protocols, advances in diagnosis and management, and innovative translational research advances that impact women’s health care Women Health 2019 will be an opportunity to meet and gather with colleagues from different countries and other parts of France.

Conference Objectives:

  • To facilitate opportunities for networking, collaboration and exchange of ideas with internationally renowned leaders in Women Health and Breast Cancer research and development.
  • To identify research and practice-based innovations in Women Health and Breast Cancer research and development.
  •  To debate gaps and priorities for sustainable development in Women Health and Breast Cancer research.
  • To discuss and debate the challenges and opportunities in the new era of Women Health and Breast Cancer research.
  • To identify opportunities for evidence-based practice in Women Health and Breast Cancer research.
  • Highly organized and structured Scientific programs in Women Health and Breast Cancer research and development.
  • Poster presentation and world-class exhibitions.
  • Meet with new vendors and suppliers.

 

SCIENTIFIC SESSIONS

Session 1: Pregnancy and Women Health

Preparation and Planning for pregnancy, Immunization during pregnancy, Nutrition, Prenatal care, delivery, and postpartum care, High-risk pregnancy care (maternal-foetal medicine), Counselling and practical advice during pregnancy and parenthood, Emergency birth control/emergency contraception, Postpartum depression, Multiple Pregnancy: Twins or more, Adolescent Pregnancy, Miscarriage,  Depression during and after pregnancy

Session 2: Maternal-Child Health

Safe motherhood, Child Health Care, Current issues in Maternal Health, Maternal Morbidity and Mortality, Quality of care, Stillbirth, Breastfeeding, , high blood pressure , Intensive Care, Neonatology, Fatal and Perinatal Therapy, Neonatal Drugs, Congenital Malformations and Birth Complications, Neonatal and foetal Nutrition, Major causes of Maternal Mortality -Haemorrhage, infection, Neonatal Infectious Disease and Antibiotics, Vaccination and Immunization, unsafe abortion and obstructed labour

 

Session 3: Breast Health

Breast biopsy, Fibrocystic Breasts, Breast Lumps, Mammogram, Breast Ultrasound, Risk and Prevention, Prognosis and Response Prediction, Imaging and Screening, Clinical Trials, Breast-Conserving Surgery (Lumpectomy or Partial Mastectomy), Advanced Disease Treatment, Cancer Support: Coping with Cancer Treatments, Biomarkers for Breast Cancer, Breast Cancer

Session 4: Breast Cancer Therapy and Survivorship

Biology of Breast Cancer, Screening and Diagnosis, Breast Cancer Therapy, Chemotherapy, Breast Cancer during pregnancy, Advanced Disease Treatment, Adjuvant Therapy, Dealing with cancer diagnosis, Survivorship after treatment, Psychosocial Quality of life, Follow up medical care, Late side effects of Cancer treatment, Care for survivors, Reconstruction of Breast, Breast Cancer Immunotherapy and Radiography, Life after Cancer treatment

Session 5: Gynaecological Cancer

Genetics of Breast and Gynecologic Cancers, Radiation Treatment for Cancer, Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Screening and Treatment of Cancer, Cancer Staging and Grading

Session 6: Menstruation and Menopause

Puberty, Menstrual Cycle: Dealing with Cramps, Menstrual Disorders, Premenstrual Syndrome (PMS), Hormonal changes, Menopause, Endometriosis uterus, surgical menopause and Menopausal hormone therapy, Endometriosis, Endometrial Ablation, Neurological condition during cycle

 

Session 7: Midwifery

Birthing assistance otherwise called obstetrics is a wellbeing science and wellbeing calling that arrangements with pregnancy, labor, and the baby blues period (counting care of the new-conceived), other than the sexual and regenerative strength of ladies for the duration of their lives. Maternity care is a restorative calling which is extraordinary for its autonomous and direct particular training, ought not to be mistaken for a medicinal claim to fame. Birthing assistant is a man who is proficient in Midwifery. Ladies ought to be empowered and offered maternity care drove congruity models of consideration with an alert in applying this gadget with generous therapeutic or Obstetric inconveniences. This Midwifery-drove care is related with a decrease in the utilization of epidurals with less episiotomies and diminished danger of losing the tyke before 24 weeks incubation. Midwifery Health Science

Session 8: Sexually transmitted infections (STDs, STIs)

Sexually transmitted infections (STIs) including chlamydia, gonorrhea, trichomoniasis, genital herpes, genital warts, HIV, and syphilis., sepsis, pneumonia, neonatal conjunctivitis, and congenital deformities, Mother-to-child transmission leading to outcomes such as stillbirths and neonatal deaths among low-birth-weight and prematurity

Session 9: Reproductive Health and Rights

Contraception and Family Planning, Termination of Pregnancy, Human Sexuality, Sexual and Reproductive Rights, , Gender and reproductive rights, Domestic Violence, Addressing Maternal Mortality, Sustained Development Goals, Medical Education and Training, Information Technology in Women’s Health and Ethics and Law in Women’s Health, Sexual Abuse: Signs and Symptoms Awareness and Counselling in Sexual and Reproductive Health

Session 10: Infertility

Reproductive Endocrinology, Female infertility, Male Infertility, Recurrent pregnancy loss, Surrogates, and Gestational Carriers, Management of Subfertility, In vitro fertilization (IVF), Intracytoplasmic sperm injection (ICSI), Conception devices, Oncofertility, Medical ethic Medicines to stimulate ovulation, Intrauterine insemination

Session 11: Autoimmune Disorders and Women

Contraception and Family Planning, Termination of Pregnancy, Human Sexuality, Sexual and Reproductive Rights, Gender and reproductive rights, Awareness and Counselling in Sexual and Reproductive Health, Domestic Violence, Addressing Maternal Mortality, Sustained Development Goals, Medical Education and Training, Sexual Abuse: Signs and Symptoms, Information Technology in Women’s Health and Ethics and Law in Women’s Health

 

Addressing Maternal Mortality, Sustainable Development Goals, Medical Education and Training, Sexual Abuse: Signs and Symptoms

 

Session 13: Polycystic ovary syndrome

Polycystic ovary syndrome (PCOS), Pathogenesis, Pelvic inflammatory disease (PID), Ovarian cysts, Pelvic organ prolapse, Health effects, Diet and lifestyle, Medical treatments, Complications of PCOS, Latest research and advancement,  Diagnosis, Pregnancy and PCOS, Uterine and vaginal prolapse

Session 14: Cosmeceutical 

The science of skin health and skin ageing, Performance testing for innovative claims, Dermatological procedure, Advances in cosmetic and plastic surgery, Anti-aging advanced techniques, Body-contouring and reshaping, Dermal fillers, breast and lip augmentation, Consumer acceptance for natural holistic healthcare, Food-cosmetic interface and interaction, Safety and efficacy, Impact of technology and the regulatory challenges, Advances in cosmetic and plastic surgery

Session 15: Osteoporosis and Bone Health

Pathophysiology, Osteoporosis and Nutrition, Bone Remodelling, Diagnosis and treatment of Osteoporosis in Postmenopausal Women, Biochemical Markers, and Traditional Herbal Medicine for Osteoporosis, Treatment of Osteoporosis, Drug Therapy, Calcium supplements for osteoporosis, hormone therapy, Bone Marrow Adiposeness in Osteoporosis

Session 16: Urogynecology

The basis of abnormal pelvic support, Preventive Urogynecology, Abnormal uterine bleeding and dysfunctional uterine bleeding, Ovarian Cysts,  Incontinence  – Management and Surgery and Genital Trauma and Fistulae, Genital Prolapse – Management and Surgery

Session 17: Reduction Mammaplasty

Reduction mammoplasty in like manner bosom diminishment and decreasing mammaplasty is the plastic medical procedure method for diminishing the range of generous bosom. In a bosom diminishment medical procedure for re-developing an utilitarian bust that is proportionate to the woman's body, the fundamental therapeutic idea is the tissue possibility of the areola complex NAC, to ensure the down to earth affectability and lactational capacity of the bosom. The signs for bosom diminishment medical procedure are three-cover physical, in vogue, and mental the recovery of the bust, of the woman's psychological self-picture, and of her mental prosperity.

 

Session 19: Breast Cancer

The bosom tumor is the disease that creates from bosom tissues. Side effects may incorporate a protuberance in the bosom, change fit as a fiddle, dimpling of the skin, liquid originating from the areola, a recently upset areola, or a red or textured fix of the skin. Dangers of building up the bosom malignancy being a female incorporates, weight, absence of physical exercise, drinking liquor, hormone substitution treatment amid menopause, ionizing radiation, early age at first feminine cycle, having kids late or not in any manner, more established age, earlier history of bosom tumor, and family history. In metastasis phases of bosom malignancy, there might be bone agony, swollen lymph, shortness of breath, or yellow skin. Transformations in the tumor smothering qualities and oncogenes prompt improvement of the malignancy. Bosom dangerous neoplastic sicknesses are the most widely recognized growth analyzed among ladies in both created and creating nations. . Geographic attractive declination in relative occurrence is the opposite of cervical disease, being most elevated in Northern US and least in Eastern and Middle Africa, however passing rate rates are generally consistent, bringing about a wide change on the off chance that mortality, extending from 25% in created districts to 37% in creating areas, and with 62% of passings happening in creating nations. Hormone replacement therapy (HRT)

 

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!